APTO
Aptose Biosciences Inc

7,054
Mkt Cap
$4.49M
Volume
320.00
52W High
$12.49
52W Low
$0.6363
PE Ratio
-0.08
APTO Fundamentals
Price
$1.30
Prev Close
$1.32
Open
$1.30
50D MA
$1.20
Beta
-0.00
Avg. Volume
2,173.76
EPS (Annual)
-$36.38
P/B
-0.23
Rev/Employee
$0.00
Loading...
Loading...
Aptose Biosciences, Inc. is a clinical-stage oncology company, which engages in the discovery, research, and development of anti-cancer therapies. Its product pipeline includes APTO-253, a small molecule that induces expression of the Kruppel-Like Factor 4 genes; and CG-806 a non-covalent small molecule therapeutic agent. The company was founded on September 5, 1986 and is headquartered in Toronto, Canada.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
13

Frequently Asked Questions

What is Market Cap of Aptose Biosciences Inc?
What is the 52-week high for Aptose Biosciences Inc?
What is the 52-week low for Aptose Biosciences Inc?
What is Aptose Biosciences Inc stock price today?
What was Aptose Biosciences Inc stock price yesterday?
What is the PE ratio of Aptose Biosciences Inc?
What is the Price-to-Book ratio of Aptose Biosciences Inc?
What is the 50-day moving average of Aptose Biosciences Inc?
How many employess does Aptose Biosciences Inc has?

Latest APTO News

View

Advertisement|Remove ads.

Advertisement|Remove ads.